0001209191-14-003733.txt : 20140117 0001209191-14-003733.hdr.sgml : 20140117 20140117161737 ACCESSION NUMBER: 0001209191-14-003733 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140116 FILED AS OF DATE: 20140117 DATE AS OF CHANGE: 20140117 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEIDEN JEFFREY M CENTRAL INDEX KEY: 0001242825 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 14535332 MAIL ADDRESS: STREET 1: 40 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2014-01-16 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001242825 LEIDEN JEFFREY M C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 1 1 0 0 CEO & President Common Stock 2014-01-16 4 M 0 45000 29.98 A 227925 D Common Stock 2014-01-16 4 S 0 45000 80.00 D 182925 D Common Stock 440 I 401(k) Stock Option 29.98 2014-01-16 4 M 0 45000 0.00 D 2021-12-13 Common Stock 45000 413108 D Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1. The option vests in 16 quarterly installments from 12/14/2011. Kenneth L. Horton, Attorney-In-Fact 2014-01-17